Evergreen Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.8M Buy
171,348
+19,955
+13% +$1.38M 0.36% 77
2025
Q1
$10.7M Buy
151,393
+119,688
+378% +$8.45M 0.36% 73
2024
Q4
$2.73M Buy
31,705
+2,148
+7% +$185K 0.09% 213
2024
Q3
$3.52M Buy
29,557
+250
+0.9% +$29.8K 0.12% 190
2024
Q2
$4.18M Buy
29,307
+1,710
+6% +$244K 0.15% 157
2024
Q1
$3.57M Buy
27,597
+145
+0.5% +$18.8K 0.13% 171
2023
Q4
$2.84M Sell
27,452
-313
-1% -$32.4K 0.12% 194
2023
Q3
$2.52M Buy
27,765
+397
+1% +$36.1K 0.11% 198
2023
Q2
$2.21M Buy
27,368
+564
+2% +$45.6K 0.09% 206
2023
Q1
$2.14M Buy
26,804
+2,736
+11% +$219K 0.1% 206
2022
Q4
$1.63M Sell
24,068
-628
-3% -$42.5K 0.08% 230
2022
Q3
$1.23M Buy
24,696
+798
+3% +$39.8K 0.06% 241
2022
Q2
$1.33M Buy
23,898
+3,076
+15% +$171K 0.07% 230
2022
Q1
$1.16M Buy
20,822
+1,334
+7% +$74.1K 0.05% 269
2021
Q4
$1.09M Buy
19,488
+588
+3% +$32.9K 0.04% 272
2021
Q3
$907K Buy
18,900
+582
+3% +$27.9K 0.04% 293
2021
Q2
$767K Buy
18,318
+1,078
+6% +$45.1K 0.04% 291
2021
Q1
$581K Buy
17,240
+2,028
+13% +$68.3K 0.03% 304
2020
Q4
$531K Buy
15,212
+1,100
+8% +$38.4K 0.03% 279
2020
Q3
$490K Buy
14,112
+492
+4% +$17.1K 0.03% 265
2020
Q2
$446K Sell
13,620
-3,184
-19% -$104K 0.03% 254
2020
Q1
$506K Sell
16,804
-1,578
-9% -$47.5K 0.05% 217
2019
Q4
$532K Sell
18,382
-216
-1% -$6.25K 0.04% 243
2019
Q3
$481K Buy
18,598
+4,632
+33% +$120K 0.04% 230
2019
Q2
$356K Buy
13,966
+2,644
+23% +$67.4K 0.03% 280
2019
Q1
$296K Sell
11,322
-1,472
-12% -$38.5K 0.03% 289
2018
Q4
$295K Buy
12,794
+234
+2% +$5.4K 0.03% 273
2018
Q3
$296K Buy
12,560
+278
+2% +$6.55K 0.03% 291
2018
Q2
$283K Buy
12,282
+208
+2% +$4.79K 0.03% 288
2018
Q1
$297K Buy
+12,074
New +$297K 0.03% 268